DK0861068T3 - Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse - Google Patents

Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse

Info

Publication number
DK0861068T3
DK0861068T3 DK96938066T DK96938066T DK0861068T3 DK 0861068 T3 DK0861068 T3 DK 0861068T3 DK 96938066 T DK96938066 T DK 96938066T DK 96938066 T DK96938066 T DK 96938066T DK 0861068 T3 DK0861068 T3 DK 0861068T3
Authority
DK
Denmark
Prior art keywords
homogenizer
bar
drug
preparing
predispersion
Prior art date
Application number
DK96938066T
Other languages
Danish (da)
English (en)
Inventor
Bernd Klinksiek
Said Mahiout
Ricarda-Christine Nothelle
Hans-Juergen Hamann
Juergen Sdebik
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0861068T3 publication Critical patent/DK0861068T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/46—Homogenising or emulsifying nozzles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/70—Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming
    • B01F33/71—Mixers specially adapted for working at sub- or super-atmospheric pressure, e.g. combined with de-foaming working at super-atmospheric pressure, e.g. in pressurised vessels
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
DK96938066T 1995-11-15 1996-11-04 Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse DK0861068T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19542499A DE19542499A1 (de) 1995-11-15 1995-11-15 Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
PCT/EP1996/004795 WO1997017946A2 (de) 1995-11-15 1996-11-04 Verfahren und vorrichtung zur herstellung einer parenteralen arzneistoff-zubereitung

Publications (1)

Publication Number Publication Date
DK0861068T3 true DK0861068T3 (da) 2002-12-02

Family

ID=7777475

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96938066T DK0861068T3 (da) 1995-11-15 1996-11-04 Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse

Country Status (11)

Country Link
US (1) US6331314B1 (https=)
EP (1) EP0861068B1 (https=)
JP (1) JP4049391B2 (https=)
AT (1) ATE222097T1 (https=)
CA (1) CA2237554C (https=)
DE (2) DE19542499A1 (https=)
DK (1) DK0861068T3 (https=)
ES (1) ES2180807T3 (https=)
MX (1) MX9803633A (https=)
PT (1) PT861068E (https=)
WO (1) WO1997017946A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1008380B1 (en) 1998-12-07 2004-03-10 F. Hoffmann-La Roche Ag Method and device for mixing or dispersing liquids
US20020119188A1 (en) * 2000-02-08 2002-08-29 Susan Niemiec Method of manufacturing liposomes
EP1222957A1 (en) * 2000-12-22 2002-07-17 Société des Produits Nestlé S.A. Process and device for producing a food grade oil-in-water emulsion
DE102004055507A1 (de) * 2004-11-17 2006-05-18 Basf Ag Verfahren zur Herstellung feinteiliger flüssig-flüssig Formulierungen und Vorrichtung zur Herstellung feinteiliger flüssig-flüssig Formulierungen
US20070231823A1 (en) * 2006-03-23 2007-10-04 Mckernan Kevin J Directed enrichment of genomic DNA for high-throughput sequencing
US7985058B2 (en) * 2007-01-12 2011-07-26 Mark Gray Method and apparatus for making uniformly sized particles
US7652175B2 (en) * 2007-06-27 2010-01-26 H R D Corporation High shear process for the production of acetaldehyde
US7479576B1 (en) * 2007-06-27 2009-01-20 H R D Corporation Method of hydrogenating aldehydes and ketones
US7491856B2 (en) 2007-06-27 2009-02-17 H R D Corporation Method of making alkylene glycols
US8304584B2 (en) 2007-06-27 2012-11-06 H R D Corporation Method of making alkylene glycols
WO2009001323A2 (en) * 2007-06-28 2008-12-31 The Procter & Gamble Company Apparatus and method for mixing of fluids by producing shear and/or cavitation, and components for such an apparatus
US8322910B2 (en) 2008-07-25 2012-12-04 The Procter & Gamble Company Apparatus and method for mixing by producing shear and/or cavitation, and components for apparatus
CN101617990B (zh) * 2009-07-31 2013-01-23 中国人民解放军第三军医大学 脂质体制备装置以及使用该装置制备脂质体的方法
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
RS52748B (sr) 2009-12-03 2013-08-30 Novartis Ag Cirkulacija komponenti tokom homogenizacije emulzija
EP2506832B1 (en) 2009-12-03 2014-02-26 Novartis AG Hydrophilic filtration during manufacture of vaccine adjuvants
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056884B4 (de) * 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CN120529961A (zh) * 2023-01-17 2025-08-22 帝斯曼知识产权资产管理有限公司 液体分散体制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529561A (en) * 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
EP0082877A1 (en) * 1981-07-06 1983-07-06 Rush-Presbyterian-St.Luke's Medical Center Preparation of synthetic erythrocytes
CA1264668A (en) * 1984-06-20 1990-01-23 Pieter R. Cullis Extrusion techniques for producing liposomes
DE3515335C2 (de) 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung
JPH08505312A (ja) * 1992-10-16 1996-06-11 ザックセ，アンドレアス 液状分散系を製造する方法及び装置
DE4328331A1 (de) * 1993-08-18 1995-02-23 Andreas Dr Sachse Kontinuierliches Hochdruckextrusionsverfahren zur Herstellung von Liposomen und Emulsionen

Also Published As

Publication number Publication date
JP2000500146A (ja) 2000-01-11
EP0861068A2 (de) 1998-09-02
CA2237554A1 (en) 1997-05-22
DE59609564D1 (de) 2002-09-19
WO1997017946A2 (de) 1997-05-22
DE19542499A1 (de) 1997-05-22
JP4049391B2 (ja) 2008-02-20
EP0861068B1 (de) 2002-08-14
ES2180807T3 (es) 2003-02-16
ATE222097T1 (de) 2002-08-15
MX9803633A (es) 1998-09-30
CA2237554C (en) 2007-01-09
US6331314B1 (en) 2001-12-18
WO1997017946A3 (de) 1997-09-12
PT861068E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
DK0861068T3 (da) Fremgangsmåde og apparat til fremstilling af et lægemiddel til parenteral indgivelse
WO2001036018A3 (en) Method and apparatus for relieving ailments using gases to increase the effectiveness of drugs
TW347339B (en) Oral delivery of discrete units
CA2224074A1 (en) System and method for producing drug-loaded microparticles
EP1008380A3 (en) Process and apparatus for mixing or dispersing liquids
EP0711127A4 (en) METHOD FOR PREPARING LIPOSOMES WITH GAS INCLUDED
DK0737064T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske doseringsformer af hydrofobe stoffer
DE69505677D1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
ATE189403T1 (de) Vorrichtung zum verabreichen von pharmazeutischen substanzen
GEP20022707B (en) Biodegrading Macromers for the Controlled Release of Biologically Active Substances
EP0689426A4 (en) THERAPEUTIC ACTIVE SUBSTANCE FOR TREATING MELANOMAS
IL140848A0 (en) Treatment regimen for administration of phenylacetylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
IL150528A0 (en) Ibuprofen containing active agent preparation
GR3018064T3 (en) Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof.
AU5658196A (en) Method for pharmaceutical delivery
IL152074A0 (en) Pharmaceutical preparations and their manufacture
EP1767230A3 (en) Apparatus and method for blood oxygenation
DK0804175T3 (da) Fremgangsmåde og anordning til fremstilling af en fladeformet indgivelsesform med et præparat, der indeholder aktive lægemi
AU2001239625A1 (en) Method of preparing solid dispersions
MY100780A (en) Azumolene dosage form.
ZA987480B (en) Process for preparing contrast agents.
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
De Leede et al. Rectal infusion of the model drug antipyrine with an osmotic delivery system
EP1288311A3 (en) Method for testing small pharmaceutically active molecules in the activation of Pax4 and production of insulin producing beta-cells